Low dose of lipopolysaccharide pretreatment can alleviate the in?ammatory response in wound infection mouse model.
- Author:
Dong WANG
1
;
Yang LIU
;
Yan-Rui ZHAO
;
Jun-Lin ZHOU
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Disease Models, Animal; Female; Inflammation; prevention & control; Lipopolysaccharides; therapeutic use; Mice; Mice, Inbred BALB C; Surgical Wound Infection; drug therapy; Toll-Like Receptor 4; physiology
- From: Chinese Journal of Traumatology 2016;19(4):193-198
- CountryChina
- Language:English
-
Abstract:
PURPOSETo assess the effects of lipopolysaccharide (LPS) pretreatment on wound infection mouse model and evaluate the biological safety of the optimal pretreatment dose in vivo.
METHODSMice were pretreated with LPS of different doses at 48 and 24 h before femoral medial lon- gitudinal incision was made and infected with different bacteria.
RESULTSIt is showed that 0.5 mg/kg/time of LPS pretreatment can significantly alleviate the inflammation in mouse model infected with methicillin-resistances Staphylococcus aureus, methicillin-sensitive S. aureus, Pseudomonas aeruginosa,or Escherichia coli compared with doses of 0.25 mg/kg/time, 1 mg/ kg/time, and 1.5 mg/kg/time.
CONCLUSIONSLPS pretreatment can alleviate the inflammation in mouse model and the optimal dose is 0.5 mg/kg/time, and meanwhile it does not damage organs' function.
